# Anaheim Bio funding rounds and investors

As of 5 Nov 2026, Anaheim Bio has raised $44.9M across 1 verified round on record (amounts in other currencies converted to USD); latest: €40 million Series A, announced 5 Nov 2026.

Anaheim Bio is unlocking the power of small molecules to transform disease and improve patients' lives.

Website: https://anaheimbio.com  
Headquarters: Leiden, the Netherlands  
Page: https://fireround.dev/companies/anaheim-bio

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-11-05 | Series A | €40 million | not stated | Droia, Frazier Life Sciences, Novartis, RTW Investments, RV Invest, Thuja Capital | [prnewswire.com](https://www.prnewswire.com/news-releases/anaheim-bio-launches-with-40-million-series-a-financing-to-advance-ana-1-for-calcium-pyrophosphate-deposition-disease-into-the-clinic-302929911.html), [bebeez.eu](https://bebeez.eu/2026/11/05/anaheim-bio-launches-with-e40-million-series-a-financing-to-advance-ana-1-for-calcium-pyrophosphate-deposition-disease-into-the-clinic), [boerse.de](https://www.boerse.de/nachrichten/EQS-News-Anaheim-Bio-Launches-with-Euro40-Million-Series-A-Financing-to-Advance-ANA-1-for-Calcium-Pyrophosphate-Deposition-Disease-into-the-Clinic/38705649) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.